These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 34473841)

  • 1. Thrombosis of the palmar digital vein after Oxford-AstraZeneca COVID-19 vaccination.
    Chen YA; Huang HY; Wu SH; Huang TC
    Int J Dermatol; 2021 Nov; 60(11):e469-e471. PubMed ID: 34473841
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of ANCA-associated vasculitis after AZD1222 (Oxford-AstraZeneca) SARS-CoV-2 vaccination: casualty or causality?
    Villa M; Díaz-Crespo F; Pérez de José A; Verdalles Ú; Verde E; Almeida Ruiz F; Acosta A; Mijaylova A; Goicoechea M
    Kidney Int; 2021 Oct; 100(4):937-938. PubMed ID: 34416184
    [No Abstract]   [Full Text] [Related]  

  • 3. Case study of thrombosis and thrombocytopenia syndrome following administration of the AstraZeneca COVID-19 vaccine.
    Saleh A; Collins J
    Aust J Gen Pract; 2021 Nov; 50():. PubMed ID: 34781321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Portal Vein Thrombosis due to Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) after Covid Vaccination with ChAdOx1 nCoV-19.
    Strobel D; Haberkamp S; Zundler S
    Ultraschall Med; 2021 Oct; 42(5):551-552. PubMed ID: 34598301
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxford-AstraZeneca COVID-19 vaccine-induced cerebral venous thrombosis and thrombocytopaenia: A missed opportunity for a rapid return of experience.
    Geeraerts T; Montastruc F; Bonneville F; Mémier V; Raposo N;
    Anaesth Crit Care Pain Med; 2021 Aug; 40(4):100889. PubMed ID: 34033927
    [No Abstract]   [Full Text] [Related]  

  • 6. Possible Risk of Thrombotic Events following Oxford-AstraZeneca COVID-19 Vaccination in Women Receiving Estrogen.
    Soltani Hekmat A; Javanmardi K
    Biomed Res Int; 2021; 2021():7702863. PubMed ID: 34734086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH.
    Oldenburg J; Klamroth R; Langer F; Albisetti M; von Auer C; Ay C; Korte W; Scharf RE; Pötzsch B; Greinacher A
    Hamostaseologie; 2021 Jun; 41(3):184-189. PubMed ID: 33822348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained COVID-19 vaccine willingness after safety concerns over the Oxford-AstraZeneca vaccine.
    Sønderskov KM; Dinesen PT; Østergaard SD
    Dan Med J; 2021 Mar; 68(5):. PubMed ID: 33870886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A personal experience of COVID-19 vaccination in pregnancy.
    Priyanka ; Choudhary OP
    Int J Surg; 2021 Nov; 95():106160. PubMed ID: 34728418
    [No Abstract]   [Full Text] [Related]  

  • 10. Interrupting vaccination policies can greatly spread SARS-CoV-2 and enhance mortality from COVID-19 disease: The AstraZeneca case for France and Italy.
    Faranda D; Alberti T; Arutkin M; Lembo V; Lucarini V
    Chaos; 2021 Apr; 31(4):041105. PubMed ID: 34251248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2.
    Tølbøll Sørensen AL; Rolland M; Hartmann J; Harboe ZB; Roed C; Jensen TØ; Kolte L; El Fassi D; Hillingsø J; Radziwon-Balicka A; Soyka RS; Hansen K; Kirkby N; Goetze JP; Gybel-Brask M; Leinøe EB; Hvas AM; Kampmann P; Stensballe J
    Blood Adv; 2021 Jun; 5(12):2569-2574. PubMed ID: 34137813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haematuria, a widespread petechial rash, and headaches following the Oxford AstraZeneca ChAdOx1 nCoV-19 Vaccination.
    Waraich A; Williams G
    BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34620638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cerebral vein/venous sinus thrombosis with thrombocytopenia syndrome after COVID-19 vaccination].
    Kawano H; Hashimoto Y; Hirano T
    Rinsho Shinkeigaku; 2021 Sep; 61(9):594-601. PubMed ID: 34373413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboaspiration and fibrinolysis infusion for portomesenteric thrombosis after AstraZeneca COVID-19 vaccine administration.
    Barral M; Arrive L; El Mouhadi-Barnier S; Cornelis FH
    Intensive Care Med; 2021 Sep; 47(9):1034-1036. PubMed ID: 34132839
    [No Abstract]   [Full Text] [Related]  

  • 15. Thrombosis after covid-19 vaccination.
    Hunter PR
    BMJ; 2021 Apr; 373():n958. PubMed ID: 33853865
    [No Abstract]   [Full Text] [Related]  

  • 16. The reversible tinnitus and cochleopathy followed first-dose AstraZeneca COVID-19 vaccination.
    Tseng PT; Chen TY; Sun YS; Chen YW; Chen JJ
    QJM; 2021 Nov; 114(9):663-664. PubMed ID: 34297133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombosis in peripheral artery disease and thrombotic thrombocytopenia after adenoviral COVID-19 vaccination.
    Crea F
    Eur Heart J; 2021 Oct; 42(39):3995-3999. PubMed ID: 34649281
    [No Abstract]   [Full Text] [Related]  

  • 18. A case of myopericarditis with pleuritis following AstraZeneca Covid-19 vaccination.
    Hung YP; Sun KS
    QJM; 2022 Jan; 114(12):879-881. PubMed ID: 34741522
    [No Abstract]   [Full Text] [Related]  

  • 19. What scientists do and don't know about the Oxford-AstraZeneca COVID vaccine.
    Mallapaty S; Callaway E
    Nature; 2021 Apr; 592(7852):15-17. PubMed ID: 33762708
    [No Abstract]   [Full Text] [Related]  

  • 20. Deep vein thrombosis more than two weeks after vaccination against COVID-19.
    Haakonsen HB; Nystedt A
    Tidsskr Nor Laegeforen; 2021 Apr; 141():. PubMed ID: 33928773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.